| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |